JP2006513701A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006513701A5 JP2006513701A5 JP2004542913A JP2004542913A JP2006513701A5 JP 2006513701 A5 JP2006513701 A5 JP 2006513701A5 JP 2004542913 A JP2004542913 A JP 2004542913A JP 2004542913 A JP2004542913 A JP 2004542913A JP 2006513701 A5 JP2006513701 A5 JP 2006513701A5
- Authority
- JP
- Japan
- Prior art keywords
- probe
- sequence
- target
- label
- probe according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000523 sample Substances 0.000 claims 298
- 230000000295 complement Effects 0.000 claims 86
- 238000006243 chemical reaction Methods 0.000 claims 76
- 238000004166 bioassay Methods 0.000 claims 62
- 238000001514 detection method Methods 0.000 claims 49
- 230000002452 interceptive Effects 0.000 claims 35
- 239000000411 inducer Substances 0.000 claims 34
- 230000027455 binding Effects 0.000 claims 33
- 230000000368 destabilizing Effects 0.000 claims 33
- 230000001809 detectable Effects 0.000 claims 30
- 108020003175 receptors Proteins 0.000 claims 23
- 102000005962 receptors Human genes 0.000 claims 23
- 150000001875 compounds Chemical class 0.000 claims 22
- 239000003446 ligand Substances 0.000 claims 21
- 239000000126 substance Substances 0.000 claims 20
- 230000001939 inductive effect Effects 0.000 claims 19
- 238000003776 cleavage reaction Methods 0.000 claims 17
- 150000007523 nucleic acids Chemical group 0.000 claims 17
- 235000018102 proteins Nutrition 0.000 claims 14
- 102000004169 proteins and genes Human genes 0.000 claims 14
- 108090000623 proteins and genes Proteins 0.000 claims 14
- OAICVXFJPJFONN-UHFFFAOYSA-N phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims 13
- 230000002708 enhancing Effects 0.000 claims 12
- 239000003112 inhibitor Substances 0.000 claims 12
- 230000002401 inhibitory effect Effects 0.000 claims 12
- 210000004027 cells Anatomy 0.000 claims 11
- 239000003623 enhancer Substances 0.000 claims 11
- 239000000758 substrate Substances 0.000 claims 11
- 229940088598 Enzyme Drugs 0.000 claims 10
- 102000004190 Enzymes Human genes 0.000 claims 10
- 108090000790 Enzymes Proteins 0.000 claims 10
- 230000003993 interaction Effects 0.000 claims 10
- 108020004707 nucleic acids Proteins 0.000 claims 10
- 210000001519 tissues Anatomy 0.000 claims 10
- 102000001253 Protein Kinases Human genes 0.000 claims 9
- 238000002844 melting Methods 0.000 claims 9
- 102000033147 ERVK-25 Human genes 0.000 claims 8
- 108091005771 Peptidases Proteins 0.000 claims 8
- 239000004365 Protease Substances 0.000 claims 8
- 239000002773 nucleotide Substances 0.000 claims 8
- 125000003729 nucleotide group Chemical group 0.000 claims 8
- 229920001850 Nucleic acid sequence Polymers 0.000 claims 7
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 claims 7
- 108091000081 Phosphotransferases Proteins 0.000 claims 6
- 108010090804 Streptavidin Proteins 0.000 claims 6
- 102000004965 antibodies Human genes 0.000 claims 6
- 108090001123 antibodies Proteins 0.000 claims 6
- 125000004429 atoms Chemical group 0.000 claims 6
- 239000003153 chemical reaction reagent Substances 0.000 claims 6
- 241000894007 species Species 0.000 claims 6
- 150000001615 biotins Chemical group 0.000 claims 5
- 230000003247 decreasing Effects 0.000 claims 5
- 239000003795 chemical substances by application Substances 0.000 claims 4
- 230000021615 conjugation Effects 0.000 claims 4
- 229920003013 deoxyribonucleic acid Polymers 0.000 claims 4
- 239000012528 membrane Substances 0.000 claims 4
- 102000009728 CDC2 Protein Kinase Human genes 0.000 claims 3
- 108010034798 CDC2 Protein Kinase Proteins 0.000 claims 3
- 108060006633 Protein Kinases Proteins 0.000 claims 3
- 102000004357 Transferases Human genes 0.000 claims 3
- 108090000992 Transferases Proteins 0.000 claims 3
- 239000000427 antigen Substances 0.000 claims 3
- 102000038129 antigens Human genes 0.000 claims 3
- 108091007172 antigens Proteins 0.000 claims 3
- 239000011324 bead Substances 0.000 claims 3
- 238000009830 intercalation Methods 0.000 claims 3
- -1 iodoacetyl group Chemical group 0.000 claims 3
- 239000011859 microparticle Substances 0.000 claims 3
- 229920000160 (ribonucleotides)n+m Polymers 0.000 claims 2
- 241000429837 Alternaria caespitosa Species 0.000 claims 2
- 206010001897 Alzheimer's disease Diseases 0.000 claims 2
- 206010059512 Apoptosis Diseases 0.000 claims 2
- 102000004657 Calcium-Calmodulin-Dependent Protein Kinase Type 2 Human genes 0.000 claims 2
- 108010003721 Calcium-Calmodulin-Dependent Protein Kinase Type 2 Proteins 0.000 claims 2
- 108010049812 Casein Kinase I Proteins 0.000 claims 2
- 102000008122 Casein Kinase I Human genes 0.000 claims 2
- 108010010919 Casein Kinase II Proteins 0.000 claims 2
- 241000701022 Cytomegalovirus Species 0.000 claims 2
- 108030005437 EC 2.7.11.12 Proteins 0.000 claims 2
- 108010064071 EC 2.7.11.19 Proteins 0.000 claims 2
- 102000014750 EC 2.7.11.19 Human genes 0.000 claims 2
- 102000009071 ErbB Receptors Human genes 0.000 claims 2
- 108010073043 ErbB Receptors Proteins 0.000 claims 2
- 210000002744 Extracellular Matrix Anatomy 0.000 claims 2
- 102000002254 Glycogen Synthase Kinase 3 Human genes 0.000 claims 2
- 108010014905 Glycogen Synthase Kinase 3 Proteins 0.000 claims 2
- 241001502974 Human gammaherpesvirus 8 Species 0.000 claims 2
- 241000725303 Human immunodeficiency virus Species 0.000 claims 2
- 102000003746 Insulin Receptor Human genes 0.000 claims 2
- 108010001127 Insulin Receptor Proteins 0.000 claims 2
- 102000003960 Ligases Human genes 0.000 claims 2
- 108090000364 Ligases Proteins 0.000 claims 2
- 108091007472 MAP kinase family Proteins 0.000 claims 2
- 102000004331 Mitogen-Activated Protein Kinases Human genes 0.000 claims 2
- 108090000823 Mitogen-Activated Protein Kinases Proteins 0.000 claims 2
- 102000031606 Phospholipid phosphatase Human genes 0.000 claims 2
- 108091017125 Phospholipid phosphatase Proteins 0.000 claims 2
- 102000003923 Protein Kinase C Human genes 0.000 claims 2
- 108090000315 Protein Kinase C Proteins 0.000 claims 2
- 102000004022 Protein-Tyrosine Kinases Human genes 0.000 claims 2
- 108090000412 Protein-Tyrosine Kinases Proteins 0.000 claims 2
- 102100019810 SRC Human genes 0.000 claims 2
- 101710009384 SRC Proteins 0.000 claims 2
- 230000036462 Unbound Effects 0.000 claims 2
- 241000700605 Viruses Species 0.000 claims 2
- 230000006907 apoptotic process Effects 0.000 claims 2
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims 2
- 229960002685 biotin Drugs 0.000 claims 2
- 235000020958 biotin Nutrition 0.000 claims 2
- 239000011616 biotin Substances 0.000 claims 2
- 230000023555 blood coagulation Effects 0.000 claims 2
- 125000002091 cationic group Chemical group 0.000 claims 2
- 230000001965 increased Effects 0.000 claims 2
- 150000002500 ions Chemical class 0.000 claims 2
- 239000000463 material Substances 0.000 claims 2
- 230000021121 meiosis Effects 0.000 claims 2
- 239000002184 metal Substances 0.000 claims 2
- 239000002105 nanoparticle Substances 0.000 claims 2
- 150000003904 phospholipids Chemical class 0.000 claims 2
- 229920001059 synthetic polymer Polymers 0.000 claims 2
- 125000003396 thiol group Chemical group [H]S* 0.000 claims 2
- RYYWUUFWQRZTIU-UHFFFAOYSA-K thiophosphate Chemical group [O-]P([O-])([O-])=S RYYWUUFWQRZTIU-UHFFFAOYSA-K 0.000 claims 2
- 238000005406 washing Methods 0.000 claims 2
- ZSLZBFCDCINBPY-ZZSFXRQLSA-N Acetyl-CoA Natural products S(C(=O)C)CCNC(=O)CCNC(=O)[C@H](O)C(CO[P@@](=O)(O[P@](=O)(OC[C@@H]1[C@@H](OP(=O)(O)O)[C@H](O)[C@@H](n2c3ncnc(N)c3nc2)O1)O)O)(C)C ZSLZBFCDCINBPY-ZZSFXRQLSA-N 0.000 claims 1
- 241000894006 Bacteria Species 0.000 claims 1
- 102000002266 Dual-Specificity Phosphatases Human genes 0.000 claims 1
- 108010000518 Dual-Specificity Phosphatases Proteins 0.000 claims 1
- 108010042407 Endonucleases Proteins 0.000 claims 1
- 241000709661 Enterovirus Species 0.000 claims 1
- 241000710831 Flavivirus Species 0.000 claims 1
- 241000233866 Fungi Species 0.000 claims 1
- 229940096919 Glycogen Drugs 0.000 claims 1
- 229920002527 Glycogen Polymers 0.000 claims 1
- BYSGBSNPRWKUQH-UJDJLXLFSA-N Glycogen Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)[C@H](O)[C@@H](O)[C@@H](O[C@@H]2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)O1 BYSGBSNPRWKUQH-UJDJLXLFSA-N 0.000 claims 1
- 102000003886 Glycoproteins Human genes 0.000 claims 1
- 108090000288 Glycoproteins Proteins 0.000 claims 1
- 108020005128 Glycosidases Proteins 0.000 claims 1
- 101710024478 HLCS Proteins 0.000 claims 1
- 102100004349 HLCS Human genes 0.000 claims 1
- 208000006454 Hepatitis Diseases 0.000 claims 1
- 208000009889 Herpes Simplex Diseases 0.000 claims 1
- 229940088597 Hormone Drugs 0.000 claims 1
- 125000002842 L-seryl group Chemical group O=C([*])[C@](N([H])[H])([H])C([H])([H])O[H] 0.000 claims 1
- 102100000794 LIG4 Human genes 0.000 claims 1
- 101700029975 LIG4 Proteins 0.000 claims 1
- 102100005410 LINE-1 retrotransposable element ORF2 protein Human genes 0.000 claims 1
- 229940040461 Lipase Drugs 0.000 claims 1
- 239000004367 Lipase Substances 0.000 claims 1
- 101700067074 MAPK Proteins 0.000 claims 1
- 101700083887 MAPK1 Proteins 0.000 claims 1
- 101710041325 MAPKAPK2 Proteins 0.000 claims 1
- 102100018545 MYLK Human genes 0.000 claims 1
- 101700047297 MYLK Proteins 0.000 claims 1
- 241000124008 Mammalia Species 0.000 claims 1
- 101700080605 NUC1 Proteins 0.000 claims 1
- 241000244206 Nematoda Species 0.000 claims 1
- 229940067631 Phospholipids Drugs 0.000 claims 1
- 108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 claims 1
- 102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 claims 1
- 241000224016 Plasmodium Species 0.000 claims 1
- 102000008662 Polynucleotide 3'-phosphatase Human genes 0.000 claims 1
- 108050000468 Polynucleotide 3'-phosphatase Proteins 0.000 claims 1
- 102000002727 Protein Tyrosine Phosphatases Human genes 0.000 claims 1
- 108020000494 Protein Tyrosine Phosphatases Proteins 0.000 claims 1
- 102000014400 SH2 domains Human genes 0.000 claims 1
- 108050003452 SH2 domains Proteins 0.000 claims 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims 1
- 206010039491 Sarcoma Diseases 0.000 claims 1
- 241000700584 Simplexvirus Species 0.000 claims 1
- 231100000765 Toxin Toxicity 0.000 claims 1
- 241000710772 Yellow fever virus Species 0.000 claims 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K [O-]P([O-])([O-])=O Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims 1
- 125000000266 alpha-aminoacyl group Chemical group 0.000 claims 1
- 239000003242 anti bacterial agent Substances 0.000 claims 1
- 230000003115 biocidal Effects 0.000 claims 1
- 101700078248 birA Proteins 0.000 claims 1
- 101710024496 birA/coaX Proteins 0.000 claims 1
- 239000007853 buffer solution Substances 0.000 claims 1
- 150000001720 carbohydrates Chemical class 0.000 claims 1
- 235000014633 carbohydrates Nutrition 0.000 claims 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 1
- 230000001268 conjugating Effects 0.000 claims 1
- 230000001419 dependent Effects 0.000 claims 1
- 239000002532 enzyme inhibitor Substances 0.000 claims 1
- 125000002485 formyl group Chemical class [H]C(*)=O 0.000 claims 1
- 150000004676 glycans Polymers 0.000 claims 1
- 231100000283 hepatitis Toxicity 0.000 claims 1
- 239000005556 hormone Substances 0.000 claims 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 1
- 238000011065 in-situ storage Methods 0.000 claims 1
- 102000006029 inositol monophosphatase family Human genes 0.000 claims 1
- 108020003233 inositol monophosphatase family Proteins 0.000 claims 1
- 102000004882 lipase Human genes 0.000 claims 1
- 108090001060 lipase Proteins 0.000 claims 1
- 235000019421 lipase Nutrition 0.000 claims 1
- 150000002632 lipids Chemical class 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 239000003068 molecular probe Substances 0.000 claims 1
- 230000003533 narcotic Effects 0.000 claims 1
- 101700006494 nucA Proteins 0.000 claims 1
- 239000002245 particle Substances 0.000 claims 1
- 239000008191 permeabilizing agent Substances 0.000 claims 1
- 239000010452 phosphate Substances 0.000 claims 1
- 150000003916 phosphatidylinositol 3,4,5-trisphosphates Chemical class 0.000 claims 1
- 150000003905 phosphatidylinositols Chemical class 0.000 claims 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-N phosphoric acid Chemical group OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims 1
- 229920000023 polynucleotide Polymers 0.000 claims 1
- 239000002157 polynucleotide Substances 0.000 claims 1
- 108010035192 polynucleotide 5'-phosphatase Proteins 0.000 claims 1
- 229920001184 polypeptide Polymers 0.000 claims 1
- 229920001282 polysaccharide Polymers 0.000 claims 1
- 239000005017 polysaccharide Substances 0.000 claims 1
- 150000004804 polysaccharides Polymers 0.000 claims 1
- OZAIFHULBGXAKX-UHFFFAOYSA-N precursor Substances N#CC(C)(C)N=NC(C)(C)C#N OZAIFHULBGXAKX-UHFFFAOYSA-N 0.000 claims 1
- 101710024887 rl Proteins 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 239000011780 sodium chloride Substances 0.000 claims 1
- 101700045897 spk-1 Proteins 0.000 claims 1
- 239000003053 toxin Substances 0.000 claims 1
- 108060008633 trl1 Proteins 0.000 claims 1
- 241001529453 unidentified herpesvirus Species 0.000 claims 1
- 230000003612 virological Effects 0.000 claims 1
- 229940051021 yellow-fever virus Drugs 0.000 claims 1
Claims (198)
b)前記第1対象配列と前記第1相補配列のうち少なくとも一つに接合されており、少なくとも一つの標的因子と特異的に相互作用する少なくとも一つの認識要素;及び
c)必要に応じて、前記第1ハイブリダイズした二重鎖の量の関数としてその大きさが示される特徴的シグナルを発生する少なくとも一つの検出可能なラベル;からなる構成成分のうち少なくとも一つ、好ましくは全部を作動可能に連結された状態に含むプローブであって、
前記標的因子が存在するときに、前記標的因子と前記認識要素との前記相互作用により前記第1ハイブリダイズした二重鎖の量が、前記標的因子が存在しないときの量に比べて変化することによって前記特徴的シグナルが変化するプローブ。 a) a first subject sequence having about 3 to 150 nucleotides each independently and substantially complementary to each other to form a first hybridized duplex; and A first nucleic acid sequence pair consisting of one complementary sequence;
b) at least one recognition element joined to at least one of the first target sequence and the first complementary sequence and specifically interacting with at least one target factor; and c) optionally, At least one, preferably all, of the components comprising: at least one detectable label that generates a characteristic signal whose magnitude is indicated as a function of the amount of said first hybridized duplex A probe included in a state connected to
When the target factor is present, the amount of the first hybridized duplex due to the interaction between the target factor and the recognition element changes compared to the amount when the target factor is not present. A probe whose characteristic signal is changed by
前記第2対象配列と前記第2相補配列はそれぞれ独立して約3〜150個のヌクレオチドを有し、相互に実質的に相補的であることから第2ハイブリダイズした二重鎖(second hybridized duplex)を形成し;
前記第1対象配列と前記第2対象配列は、一つの対象配列内に含まれていながら、少なくとも一つのヌクレオチドからなる重複領域を有し、
前記標的因子が存在するときに、前記標的因子と前記認識要素との前記相互作用により、前記標的因子が存在しないときに比べて前記第1ハイブリダイズした二重鎖及び前記第2ハイブリダイズした二重鎖のいずれか一つの量は減少し、残り一つの量は増加することによって、前記特徴的シグナルが変化する請求項1に記載のプローブ。 The probe further comprises a second nucleic acid sequence pair that is a competing nucleic acid sequence consisting of a second target sequence and a second complementary sequence,
The second target sequence and the second complementary sequence each independently have about 3 to 150 nucleotides and are substantially complementary to each other, so that the second hybridized duplex (second hybridized duplex) );
The first target sequence and the second target sequence have an overlapping region consisting of at least one nucleotide while being included in one target sequence,
Due to the interaction between the target factor and the recognition element when the target factor is present, the first hybridized duplex and the second hybridized duplex are compared to when the target factor is absent. The probe according to claim 1, wherein the characteristic signal is changed by decreasing the amount of any one of the heavy chains and increasing the amount of the remaining one.
前記第1対象配列が前記第1相補配列にハイブリダイズしていないときに、前記アーム配列対は、約3〜35個の相補的な塩基対を有するステム二重鎖(stemd duplex)を形成し;
前記検出可能なラベルは、前記5'アーム配列に接合された第1ラベル部分と前記3'アーム配列に接合された第2ラベル部分とからなる相互作用性ラベル対を含み、前記ステム二重鎖が形成されるときに、前記第1及び第2ラベル部分が相互作用する請求項1に記載のプローブ。 The probe includes a 5 ′ arm sequence covalently linked to the 5 ′ end of the first target sequence, and a 3 ′ covalently linked to the 3 ′ end of the first target sequence. A probe further comprising a nucleic acid arm sequence pair consisting of an arm sequence (3'arm sequence),
When the first target sequence is not hybridized to the first complementary sequence, the arm sequence pair forms a stemd duplex having about 3 to 35 complementary base pairs. ;
The detectable label comprises an interactive label pair consisting of a first label portion joined to the 5 ′ arm sequence and a second label portion joined to the 3 ′ arm sequence, the stem duplex The probe of claim 1, wherein the first and second label portions interact when the is formed.
前記第1対象配列が前記第1相補配列にハイブリダイズしていないときに、前記アーム配列対は、約3〜35個の相補的な塩基対を有するステム二重鎖(stem duplex)を形成し;
前記検出可能なラベルは、前記5'アーム配列に接合された第1ラベル部分と、前記3'アーム配列に接合された第2ラベル部分とからなる相互作用性ラベル対を含み、前記ステム二重鎖が形成されるときに、前記第1及び第2ラベル部分が相互作用する請求項1に記載のプローブ。 The probe includes a 5 ′ arm sequence covalently linked to the 5 ′ end of the first complementary sequence and a 3 ′ covalently linked to the 3 ′ end of the first complementary sequence. A probe further comprising a nucleic acid arm sequence pair consisting of an arm sequence (3'arm sequence),
When the first target sequence is not hybridized to the first complementary sequence, the arm sequence pair forms a stem duplex having about 3 to 35 complementary base pairs. ;
The detectable label comprises an interactive label pair consisting of a first label portion joined to the 5 ′ arm sequence and a second label portion joined to the 3 ′ arm sequence, the stem duplex The probe of claim 1, wherein the first and second label portions interact when a chain is formed.
前記第1対象配列が前記第1相補配列にハイブリダイズしていないときに、前記第1アーム配列対は、約3〜35個の相補的な塩基対を有する第1ステム二重鎖(first stem duplex)を形成し、前記第2アーム配列対は、約3〜35個の相補的な塩基対を有する第2ステム二重鎖(second stemd duplex)を形成し;
前記検出可能なラベルは、前記第1の5'アーム配列に接合された第1ラベル部分と前記第1の3'アーム配列に接合された第2ラベル部分とからなる第1ラベル対と、前記第2の5'アーム配列に接合された第3ラベル部分と前記第2の3'アーム配列に接合された第4ラベル部分とからなる第2ラベル対と、からなる2対の相互作用性ラベル対を含み、前記第1ステム二重鎖が形成されるときに前記第1ラベル対が相互作用し、前記第2ステム二重鎖が形成されるときに前記第2ラベル対が相互作用する請求項1に記載のプローブ。 The probe is covalently linked to a first 5 'arm sequence that is covalently linked to the 5' end of the first target sequence and a 3 'end of the first target sequence. A first arm sequence pair consisting of a first 3 'arm sequence and a second 5' arm sequence (second) covalently linked to the 5 'end of the first complementary sequence. 5 'arm sequence) and a second arm sequence pair consisting of a second 3' arm sequence covalently linked to the 3 'end of the first complementary sequence A probe further comprising a nucleic acid arm sequence pair of
When the first sequence of interest is not hybridized to the first complementary sequence, the first arm sequence pair is a first stem duplex having about 3 to 35 complementary base pairs (first stem duplex). the second arm sequence pair forms a second stemd duplex having about 3 to 35 complementary base pairs;
The detectable label comprises a first label pair comprising a first label portion joined to the first 5 ′ arm array and a second label portion joined to the first 3 ′ arm array; Two pairs of interactive labels comprising a third label portion joined to a second 5 'arm arrangement and a second label pair comprising a fourth label portion joined to the second 3' arm arrangement A pair comprising: the first label pair interacts when the first stem duplex is formed and the second label pair interacts when the second stem duplex is formed Item 2. The probe according to Item 1.
前記第1相補配列が前記第1対象配列にハイブリダイズしていないときに、前記アーム配列対は約3〜35個の相補的な塩基対を有するステム二重鎖(stem duplex)を形成し;
前記検出可能なラベルは、前記5'アーム配列に接合された第1ラベル部分と、前記3'アーム配列に接合された第2ラベル部分とからなる相互作用性ラベル対を含み、前記ステム二重鎖が形成されるときに、前記第1及び第2ラベル部分が相互作用する請求項2に記載のプローブ。 The probe includes a 5 ′ arm sequence covalently linked to the 5 ′ end of the first complementary sequence and a 3 ′ covalently linked to the 3 ′ end of the first complementary sequence. A probe further comprising a nucleic acid arm sequence pair consisting of an arm sequence (3'arm sequence),
The arm sequence pair forms a stem duplex having about 3 to 35 complementary base pairs when the first complementary sequence is not hybridized to the first subject sequence;
The detectable label comprises an interactive label pair consisting of a first label portion joined to the 5 ′ arm sequence and a second label portion joined to the 3 ′ arm sequence, the stem duplex The probe according to claim 2, wherein the first and second label portions interact when a chain is formed.
前記第2相補配列が前記第2対象配列にハイブリダイズしていないときに、前記アーム配列対は約3〜35個の相補的な塩基対を有するステム二重鎖(stem duplex)を形成し;
前記検出可能なラベルは、前記5'アーム配列に接合された第1ラベル部分と、前記3'アーム配列に接合された第2ラベル部分とからなる相互作用性ラベル対を含み、前記ステム二重鎖が形成されるときに、前記第1及び第2ラベル部分が相互作用する請求項2に記載のプローブ。 The probe includes a 5 ′ arm sequence covalently linked to the 5 ′ end of the second complementary sequence and a 3 ′ covalently linked to the 3 ′ end of the second complementary sequence. A probe further comprising a nucleic acid arm sequence pair consisting of an arm sequence (3'arm sequence),
The arm sequence pair forms a stem duplex having about 3 to 35 complementary base pairs when the second complementary sequence is not hybridized to the second subject sequence;
The detectable label comprises an interactive label pair consisting of a first label portion joined to the 5 ′ arm sequence and a second label portion joined to the 3 ′ arm sequence, the stem duplex The probe according to claim 2, wherein the first and second label portions interact when a chain is formed.
前記第1相補配列が前記第1対象配列にハイブリダイズしていないときに、前記第1アーム配列対は、約3〜35個の相補的な塩基対を有する第1ステム二重鎖(first stem duplex)を形成し、前記第2相補配列が前記第2対象配列にハイブリダイズしていないときに、前記第2アーム配列対は、約3〜35個の相補的な塩基対を有する第2ステム二重鎖(second stem duplex)を形成し;
前記検出可能なラベルは、前記第1の5'アーム配列に接合された第1ラベル部分と前記第1の3'アーム配列に接合された第2ラベル部分とからなる第1ラベル対と、前記第2の5'アーム配列に接合された第3ラベル部分と前記第2の3'アーム配列に接合された第4ラベル部分とからなる第2ラベル対と、からなる2対の相互作用性ラベル対を含み、前記第1ステム二重鎖が形成されるときに前記第1ラベル対が相互作用し、前記第2ステム二重鎖が形成されるときに前記第2ラベル対が相互作用する請求項2に記載のプローブ。 The probe is covalently linked to the first 5 ′ arm sequence covalently linked to the 5 ′ end of the first complementary sequence and the 3 ′ end of the first complementary sequence. A first arm sequence pair consisting of a first 3 ′ arm sequence and a second 5 ′ arm sequence (second) covalently linked to the 5 ′ end of the second complementary sequence. 5'arm sequence) and a second arm sequence pair consisting of a second 3'arm sequence covalently linked to the 3 'end of the second complementary sequence A probe further comprising a nucleic acid arm sequence pair of
When the first complementary sequence is not hybridized to the first target sequence, the first arm sequence pair has a first stem duplex having about 3 to 35 complementary base pairs (first stem duplex). the second arm sequence pair has about 3 to 35 complementary base pairs when the second complementary sequence is not hybridized to the second target sequence. Forming a second stem duplex;
The detectable label comprises a first label pair comprising a first label portion joined to the first 5 ′ arm array and a second label portion joined to the first 3 ′ arm array; Two pairs of interactive labels comprising a third label portion joined to a second 5 'arm arrangement and a second label pair comprising a fourth label portion joined to the second 3' arm arrangement A pair comprising: the first label pair interacts when the first stem duplex is formed and the second label pair interacts when the second stem duplex is formed Item 3. The probe according to Item 2.
a)前記試料を、請求項5によるプローブと接触させる段階;及び
b)前記検出温度において前記標的受容体因子がない時と比べて特徴的シグナルの大きさに変化があるか確認する段階;を含むアッセイ。 In an assay for detecting the presence or absence of at least one target receptor factor in a sample that can optionally bind to a probe ligand under conditions including a detection temperature,
a) contacting the sample with a probe according to claim 5; and b) checking if there is a change in the magnitude of the characteristic signal compared to when there is no target receptor factor at the detection temperature. Including assay.
a)前記試料を、前記プローブリガンド及び前記標的リガンドと結合しうる受容体因子の存在下で 請求項5によるプローブと接触させる段階;及び
b)前記検出温度において前記標的リガンドがない時と比べて特徴的シグナルの大きさに変化があるか確認する段階;を含むアッセイ。 In an assay for detecting the presence or absence of at least one target ligand in a sample under conditions including a detection temperature,
a) contacting the sample with the probe according to claim 5 in the presence of a receptor factor capable of binding the probe ligand and the target ligand; and b) as compared to when there is no target ligand at the detection temperature. Determining whether there is a change in the magnitude of the characteristic signal.
a)前記試料を、請求項10によるプローブと接触させる段階;及び
b)前記検出温度において前記標的反応誘発因子がない時と比べて特徴的シグナルの大きさに変化があるか確認する段階;を含むアッセイ。 In an assay for detecting the presence or absence of at least one target reaction inducer in a sample capable of specifically cleaving a cleavage site under conditions including a detection temperature,
a) contacting the sample with a probe according to claim 10; and b) checking if there is a change in the magnitude of the characteristic signal compared to when there is no target reaction inducer at the detection temperature. Including assay.
a)前記試料を、請求項23によるプローブと接触させる段階;及び
b)前記検出温度において前記標的反応誘発因子がない時と比べて特徴的シグナルの大きさに変化があるか確認する段階;を含むアッセイ。 In an assay for detecting the presence or absence of at least one target reaction inducer in a sample capable of specifically inducing a covalent bond at a reaction site under conditions including a detection temperature,
a) contacting the sample with a probe according to claim 23 ; and b) checking if there is a change in the magnitude of the characteristic signal compared to when there is no target reaction inducer at the detection temperature. Including assay.
a)前記試料を、請求項30によるプローブと接触させる段階;及び
b)前記検出温度において前記標的反応誘発因子がない時と比べて特徴的シグナルの大きさに変化があるか確認する段階;を含むアッセイ。 In an assay for detecting the presence or absence of at least one target reaction inducer in a sample capable of specifically converting a reaction site to a junction site under conditions including a detection temperature,
a) contacting the sample with a probe according to claim 30 ; and b) checking if there is a change in the magnitude of the characteristic signal compared to when there is no target reaction inducer at the detection temperature. Including assay.
a)前記試料を、請求項43によるプローブと接触させる段階;及び
b)前記検出温度において前記標的反応誘発因子がない時と比べて特徴的シグナルの大きさに変化があるか確認する段階;を含むアッセイ。 In an assay for detecting the presence or absence of at least one target reaction inducer in a sample capable of specifically converting a reactive site to a non-conjugated site under conditions including a detection temperature,
a) contacting the sample with a probe according to claim 43 ; and b) checking if there is a change in the magnitude of the characteristic signal compared to when there is no target reaction trigger at the detection temperature. Including assay.
a)標的化合物を、前記受容体因子の存在下で請求項5によるプローブと接触させる段階;及び
b)前記検出温度において前記標的化合物がない時と比べて特徴的シグナルの大きさに変化があるか確認する段階;を含むアッセイ。 In an assay for detecting an inhibitor or enhancer for binding of a receptor factor to a probe ligand under conditions including a detection temperature,
a) contacting the target compound with the probe according to claim 5 in the presence of the receptor factor; and b) a change in the magnitude of the characteristic signal compared to when there is no target compound at the detection temperature. An assay comprising:
a)標的化合物を、前記反応誘発因子の存在下で請求項10によるプローブと接触させる段階;及び
b)前記検出温度において前記標的化合物がない時と比べて前記特徴的シグナルの大きさに変化があるか確認する段階;を含むアッセイ。 In an assay for detecting an inhibitor or enhancer for a reaction inducer capable of specifically cleaving a cleavage site under conditions including a detection temperature,
a) contacting the target compound with the probe according to claim 10 in the presence of the reaction inducer; and b) a change in the magnitude of the characteristic signal compared to when there is no target compound at the detection temperature. An assay comprising the steps of:
a)標的化合物を、前記反応誘発因子及び不安定化因子の存在下で請求項23によるプローブと接触させる段階;及び
b)前記検出温度において前記標的化合物がない時と比べて前記特徴的シグナルの大きさに変化があるか確認する段階;を含むアッセイ。 In an assay for detecting an inhibitor or enhancer against at least one reaction inducer capable of specifically inducing a reactive site covalent bond under conditions including a detection temperature,
a) contacting the target compound with a probe according to claim 23 in the presence of the reaction-inducing factor and destabilizing factor; and b) the characteristic signal compared to when the target compound is absent at the detection temperature. An assay comprising: checking for a change in size.
a)標的化合物を、前記反応誘発因子及び不安定化因子の存在下で請求項30によるプローブと接触させる段階;及び
b)前記検出温度において前記標的化合物がない時と比べて前記特徴的シグナルの大きさに変化があるか確認する段階;を含むアッセイ。 In an assay for detecting an inhibitor or enhancer for at least one reaction inducer capable of specifically converting a reaction site to a junction site under conditions including a detection temperature,
a) contacting the target compound with a probe according to claim 30 in the presence of the reaction inducing factor and destabilizing factor; and b) the characteristic signal compared to when the target compound is absent at the detection temperature. An assay comprising: checking for a change in size.
a)標的化合物を、前記反応誘発因子と不安定化因子の存在下で請求項43によるプローブと接触させる段階;及び
b)前記検出温度において前記標的化合物がない時と比べて前記特徴的シグナルの大きさに変化があるか確認する段階;を含むアッセイ。 In an assay for detecting an inhibitor or enhancer for at least one reaction inducer capable of specifically converting a reactive site to a non-conjugated site under conditions including a detection temperature,
a) contacting the target compound with the probe according to claim 43 in the presence of the reaction-inducing factor and destabilizing factor; and b) the characteristic signal compared to when the target compound is absent at the detection temperature. An assay comprising: checking for a change in size.
a)前記試料を、請求項54によるプローブと接触させる段階;及び
b)前記検出温度において前記標的受容体因子がない時と比べて前記特徴的シグナルの大きさに変化があるか確認する段階;を含むアッセイ。 In an assay for detecting the presence or absence of at least one target receptor factor in a sample that can optionally bind to a probe ligand under conditions including a detection temperature,
a) contacting the sample with a probe according to claim 54 ; and
b) checking whether there is a change in the magnitude of the characteristic signal compared to when there is no target receptor factor at the detection temperature.
a)前記試料を、前記プローブリガンド及び前記標的リガンドと結合しうる受容体因子の存在下で請求項54によるプローブと接触させる段階;及び
b)前記検出温度において前記標的リガンドがない時と比べて前記特徴的シグナルの大きさに変化があるか確認する段階;を含むアッセイ。 In an assay for detecting the presence or absence of at least one target ligand in a sample under conditions including a detection temperature,
a) contacting the sample with a probe according to claim 54 in the presence of a receptor factor capable of binding the probe ligand and the target ligand;
b) confirming whether there is a change in the magnitude of the characteristic signal compared to when there is no target ligand at the detection temperature.
a)前記試料を、請求項56によるプローブと接触させる段階;及び
b)前記検出温度において前記標的反応誘発因子がない時と比べて前記特徴的シグナルの大きさに変化があるか確認する段階;を含むアッセイ。 In an assay for detecting the presence or absence of at least one target reaction inducer in a sample capable of specifically cleaving a cleavage site under conditions including a detection temperature,
a) contacting the sample with a probe according to claim 56 ; and
b) confirming whether there is a change in the magnitude of the characteristic signal compared to when there is no target reaction inducer at the detection temperature.
a)前記試料を、請求項58によるプローブと接触させる段階;及び
b)前記検出温度において前記標的反応誘発因子がない時と比べて前記特徴的シグナルの大きさに変化があるか確認する段階;を含むアッセイ。 In an assay for detecting the presence or absence of at least one target reaction inducer in a sample capable of specifically inducing a covalent bond at a reaction site under conditions including a detection temperature,
a) contacting the sample with a probe according to claim 58 ; and
b) confirming whether there is a change in the magnitude of the characteristic signal compared to when there is no target reaction inducer at the detection temperature.
a)前記試料を、請求項60によるプローブと接触させる段階;及び
b)前記検出温度において前記標的反応誘発因子がない時と比べて前記特徴的シグナルの大きさに変化があるか確認する段階;を含むアッセイ。 In an assay for detecting the presence or absence of at least one target reaction inducer in a sample capable of specifically converting a reaction site to a junction site under conditions including a detection temperature,
a) contacting the sample with a probe according to claim 60 ; and
b) confirming whether there is a change in the magnitude of the characteristic signal compared to when there is no target reaction inducer at the detection temperature.
a)前記試料を、請求項62によるプローブと接触させる段階;及び
b)前記検出温度で前記標的反応誘発因子がない時と比べて前記特徴的シグナルの大きさに変化があるか確認する段階;を含むアッセイ。 In an assay for detecting the presence or absence of at least one target reaction inducer in a sample capable of specifically converting a reactive site to a non-conjugated site under conditions including a detection temperature,
a) contacting the sample with a probe according to claim 62 ; and
b) confirming whether there is a change in the magnitude of the characteristic signal compared to when there is no target reaction inducer at the detection temperature.
a)標的化合物を、前記受容体因子の存在下で請求項54によるプローブと接触させる段階;及び
b)前記検出温度において前記標的候補化合物がない時と比べて前記特徴的シグナルの大きさに変化があるか確認する段階;を含むアッセイ。 In an assay for detecting an inhibitor or enhancer for binding of a receptor factor to a probe ligand under conditions including a detection temperature,
contacting a target compound with a probe according to claim 54 in the presence of said receptor factor; and
b) confirming whether there is a change in the magnitude of the characteristic signal compared to when there is no target candidate compound at the detection temperature.
a)標的化合物を、前記反応誘発因子の存在下で請求項56によるプローブと接触させる段階;及び
b)前記検出温度において前記標的化合物がない時と比べて前記特徴的シグナルの大きさに変化があるか確認する段階;を含むアッセイ。 In an assay for detecting an inhibitor or enhancer for a reaction inducer capable of specifically cleaving a cleavage site under conditions including a detection temperature,
contacting a target compound with a probe according to claim 56 in the presence of said reaction inducer; and
b) checking whether there is a change in the magnitude of the characteristic signal compared to when there is no target compound at the detection temperature.
a)標的化合物を、前記反応誘発因子と不安定化因子の存在下で請求項58によるプローブと接触させる段階;及び
b)前記検出温度において前記標的化合物がない時と比べて前記特徴的シグナルの大きさに変化があるか確認する段階;を含むアッセイ。 In an assay for detecting an inhibitor or enhancer against at least one reaction inducer capable of specifically inducing a reactive site covalent bond under conditions including a detection temperature,
contacting a target compound with a probe according to claim 58 in the presence of said reaction-inducing factor and destabilizing factor; and
b) checking whether there is a change in the magnitude of the characteristic signal compared to when there is no target compound at the detection temperature.
a)標的化合物を、前記反応誘発因子及び不安定化因子の存在下で請求項60によるプローブと接触させる段階;及び
b)前記検出温度において前記標的化合物がない時と比べて前記特徴的シグナルの大きさに変化があるか確認する段階;を含むアッセイ。 In an assay for detecting an inhibitor or enhancer for at least one reaction inducer capable of specifically converting a reaction site to a junction site under conditions including a detection temperature,
a) contacting the target compound with a probe according to claim 60 in the presence of said reaction inducer and destabilizing factor; and
b) checking whether there is a change in the magnitude of the characteristic signal compared to when there is no target compound at the detection temperature.
a)標的化合物を、前記反応誘発因子及び不安定化因子の存在下で請求項62によるプローブと接触させる段階;及び
b)前記検出温度において前記標的化合物がない時と比べて前記特徴的シグナルの大きさに変化があるか確認する段階;を含むアッセイ。 In an assay for detecting an inhibitor or enhancer for at least one reaction inducer capable of specifically converting a reactive site to a non-conjugated site under conditions including a detection temperature,
a) contacting the target compound with a probe according to claim 62 in the presence of said reaction inducer and destabilizing factor; and
b) checking whether there is a change in the magnitude of the characteristic signal compared to when there is no target compound at the detection temperature.
a)第1の対象配列と第1の相補配列からなる核酸配列の第1の対、ここで、前記第1の対象配列及び第1の相補配列はそれぞれ独立して、約3〜約150ヌクレオチドを含み、相互に実質的に相補的であり、第1のハイブリダイズした二重鎖を形成する; a) a first pair of nucleic acid sequences comprising a first subject sequence and a first complementary sequence, wherein the first subject sequence and the first complementary sequence are each independently about 3 to about 150 nucleotides And are substantially complementary to each other to form a first hybridized duplex;
b)前記第1の対象配列及び第1の相補配列の少なくとも1つに接合した少なくとも1つの反応性基、ここで該反応性基は、少なくとも1つの標的要素と特異的に相互作用することができる認識要素が接合できる化学部分である;及び b) at least one reactive group joined to at least one of the first subject sequence and the first complementary sequence, wherein the reactive group specifically interacts with at least one target element; A possible recognition element is a chemical moiety that can be joined; and
c)任意に、少なくとも1つの検出可能な標識、ここで該検出可能な標識は、そのレベルが、前記第1のハイブリダイズした二重鎖の量の関数である特徴的なシグナルを生成する。 c) Optionally, at least one detectable label, wherein the detectable label produces a characteristic signal whose level is a function of the amount of the first hybridized duplex.
前記第2の対象配列及び第2の相補配列はそれぞれ独立して、約3〜約150ヌクレオチドを含み、相互に実質的に相補的であり、第2のハイブリダイズした二重鎖を形成し、且つ The second subject sequence and the second complementary sequence each independently comprise from about 3 to about 150 nucleotides and are substantially complementary to each other to form a second hybridized duplex; and
前記第1及び第2の対象配列は、1つの対象配列中に含まれ、少なくとも1つのヌクレオチドからなる重複領域を有するプリプローブ。 The said 1st and 2nd object sequence is a preprobe which is contained in one object sequence, and has the overlap region which consists of at least 1 nucleotide.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US41786402P | 2002-10-11 | 2002-10-11 | |
PCT/KR2003/002101 WO2004033476A1 (en) | 2002-10-11 | 2003-10-11 | Target detection system having a conformationally sensitive probe comprising a nucleic acid based signal transducer |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2010015946A Division JP2010099090A (en) | 2002-10-11 | 2010-01-27 | Target detection system having conformationally sensitive probe comprising nucleic acid based signal transducer |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2006513701A JP2006513701A (en) | 2006-04-27 |
JP2006513701A5 true JP2006513701A5 (en) | 2006-11-30 |
Family
ID=32094107
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2004542913A Pending JP2006513701A (en) | 2002-10-11 | 2003-10-11 | Target detection system having a conformationally sensitive probe including a nucleic acid based signal transducer |
JP2010015946A Abandoned JP2010099090A (en) | 2002-10-11 | 2010-01-27 | Target detection system having conformationally sensitive probe comprising nucleic acid based signal transducer |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2010015946A Abandoned JP2010099090A (en) | 2002-10-11 | 2010-01-27 | Target detection system having conformationally sensitive probe comprising nucleic acid based signal transducer |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1558626A4 (en) |
JP (2) | JP2006513701A (en) |
AU (1) | AU2003269522A1 (en) |
WO (1) | WO2004033476A1 (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1845157A1 (en) * | 2005-01-14 | 2007-10-17 | Ngk Insulators, Ltd. | Array and hybridization method |
AU2006218794A1 (en) * | 2005-02-28 | 2006-09-08 | Gen-Probe Incorporated | Compositions and methods of detecting an analyte by using a nucleic acid hybridization switch probe |
JP2011067174A (en) * | 2009-09-28 | 2011-04-07 | Fujitsu Ltd | Target detector and method for producing the same |
FR2998969B1 (en) * | 2012-12-04 | 2015-01-09 | Univ Limoges | USE OF BIOTIN GRAFFEE FOR THE METAL DETERMINATION IN A SOLUTION |
WO2016163345A1 (en) * | 2015-04-07 | 2016-10-13 | コニカミノルタ株式会社 | Nucleic acid probe |
EP3755800A1 (en) | 2018-02-21 | 2020-12-30 | Bristol-Myers Squibb Company | Camk2d antisense oligonucleotides and uses thereof |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3785591T2 (en) * | 1986-01-10 | 1993-09-02 | Amoco Corp | COMPETITIVE HOMOGENEOUS TEST. |
US5283174A (en) * | 1987-09-21 | 1994-02-01 | Gen-Probe, Incorporated | Homogenous protection assay |
DE69010506T2 (en) * | 1989-10-04 | 1994-12-22 | Du Pont | DETERMINATION METHOD FOR BIOLOGICAL TARGET COMPLEXES ON THE SURFACE OF A BIOSENSOR. |
US5925517A (en) * | 1993-11-12 | 1999-07-20 | The Public Health Research Institute Of The City Of New York, Inc. | Detectably labeled dual conformation oligonucleotide probes, assays and kits |
EP0791008A4 (en) * | 1995-09-08 | 2003-04-23 | Anadys Pharmaceuticals Inc | Screen for compounds with affinity for rna |
EP0851228A4 (en) * | 1996-06-10 | 2000-07-26 | Lab Molecular Biophotonics | Highly sensitive fluorescent immunoassay |
US6361942B1 (en) * | 1998-03-24 | 2002-03-26 | Boston Probes, Inc. | Method, kits and compositions pertaining to detection complexes |
US6399302B1 (en) * | 1998-08-21 | 2002-06-04 | University Of Virginia Patent Foundation | Signal generating oligonucleotide-based biosensor |
DE19950969A1 (en) * | 1999-10-22 | 2001-05-10 | Aventis Res & Tech Gmbh & Co | Double-stranded nucleic acid probes and their use |
US6753141B2 (en) * | 2000-01-25 | 2004-06-22 | The University Of Utah | Simultaneous screening and identification of sequence alterations from amplified target |
EP1301626A4 (en) * | 2000-05-08 | 2004-06-02 | Qtl Biosystems Llc | Improvements to the fluorescent polymer-qtl approach to biosensing |
-
2003
- 2003-10-11 WO PCT/KR2003/002101 patent/WO2004033476A1/en active Application Filing
- 2003-10-11 EP EP03751517A patent/EP1558626A4/en not_active Withdrawn
- 2003-10-11 AU AU2003269522A patent/AU2003269522A1/en not_active Abandoned
- 2003-10-11 JP JP2004542913A patent/JP2006513701A/en active Pending
-
2010
- 2010-01-27 JP JP2010015946A patent/JP2010099090A/en not_active Abandoned
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6457564B2 (en) | Proximity extension assay using exonuclease | |
US8268554B2 (en) | Method for analyte detection using proximity probes | |
US9772330B2 (en) | Nucleic acid aptamer-based diagnostic methods with novel techniques for signal enhancement | |
JP4813011B2 (en) | Molecular constructs and uses for detecting biochemical reactions | |
US7494776B2 (en) | Labeled complementary oligonucleotides to detect oligonucleotide-linked ligands | |
US8344121B2 (en) | Nanoprobes for detection or modification of molecules | |
US20160153973A1 (en) | Device and method of rapid linker mediated label-based immunoassays | |
JP6043901B2 (en) | Blocking reagent and method for its use | |
US20030054413A1 (en) | Bio-sensing platforms for detection and quantitation of biological molecules | |
US20100159446A1 (en) | Detection Assays and Use Thereof | |
CN101988920A (en) | Antigen detection kit and method | |
Zavoiura et al. | Quantum dot-PNA conjugates for target-catalyzed RNA detection | |
CN101848939A (en) | Protein G-oligonucleotide conjugate | |
JP2010099090A5 (en) | ||
JPH10179197A (en) | Identification of nucleic acid by using triple helix formation of adjacently annealed probe | |
JP2006513701A5 (en) | ||
JP2010099090A (en) | Target detection system having conformationally sensitive probe comprising nucleic acid based signal transducer | |
US20050118603A1 (en) | Target detection system having a conformationally sensitive probe comprising a nucleic acid based signal transducer | |
US20230323424A1 (en) | Controls for proximity detection assays | |
Boireau et al. | Unique supramolecular assembly of a redox protein with nucleic acids onto hybrid bilayer: towards a dynamic DNA chip | |
Niveleau et al. | Grafting peptides onto polystyrene microplates for ELISA | |
JP2007020526A (en) | Method for highly sensitively detecting target molecule by utilization of specific bond, and kit therefor | |
JP2007516973A (en) | Metal ion mediated fluorescence superquenching assays, kits and reagents | |
Karhunen | Switchable Lanthanide Luminescence for Detection of Biomolecules |